Literature DB >> 11841346

Urokinase as a multidomain protein and polyfunctional cell regulator.

V V Stepanova1, V A Tkachuk.   

Abstract

The urokinase type plasminogen activator (urokinase) plays a pivotal role in the regulation of cell adhesion and migration during tissue remodeling. Urokinase not only specifically cleaves plasminogen and converts it into plasmin but also activates intracellular signaling upon binding to certain receptors on the cell surface. The polyfunctional properties of this protein are associated with its three-domain structure as follows: the C-terminal proteolytic domain containing the serine protease active center, the central kringle domain, and the N-terminal domain homologous to epidermal growth factor. This review considers functional properties of urokinase and of its fragments generated on the cell surface as a result of proteolytic processing. This review will discuss the mechanisms of urokinase-mediated regulation of cellular function upon binding to membrane receptors.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11841346     DOI: 10.1023/a:1013912500373

Source DB:  PubMed          Journal:  Biochemistry (Mosc)        ISSN: 0006-2979            Impact factor:   2.487


  22 in total

1.  Dissecting mannose 6-phosphate-insulin-like growth factor 2 receptor complexes that control activation and uptake of plasminogen in cells.

Authors:  Vladimir Leksa; Karin Pfisterer; Gabriela Ondrovičová; Brigitte Binder; Silvia Lakatošová; Clemens Donner; Herbert B Schiller; Alexander Zwirzitz; Katarína Mrvová; Vladimir Pevala; Eva Kutejová; Hannes Stockinger
Journal:  J Biol Chem       Date:  2012-05-21       Impact factor: 5.157

2.  High level of urokinase plasminogen activator contributes to cholangiocarcinoma invasion and metastasis.

Authors:  Parichut Thummarati; Sitsom Wijitburaphat; Aruna Prasopthum; Apaporn Menakongka; Banchob Sripa; Rutaiwan Tohtong; Tuangporn Suthiphongchai
Journal:  World J Gastroenterol       Date:  2012-01-21       Impact factor: 5.742

3.  Nebulization of Single-Chain Tissue-Type and Single-Chain Urokinase Plasminogen Activator for Treatment of Inhalational Smoke-Induced Acute Lung Injury.

Authors:  Soraya Hengsawas Surasarang; Sawittree Sahakijpijarn; Galina Florova; Andrey A Komissarov; Christina L Nelson; Enkhbaatar Perenlei; Satoshi Fukuda; Marla R Wolfson; Thomas H Shaffer; Steven Idell; Robert O Williams
Journal:  J Drug Deliv Sci Technol       Date:  2018-04-30       Impact factor: 3.981

4.  Platelet-derived growth factor D is activated by urokinase plasminogen activator in prostate carcinoma cells.

Authors:  Carolyn V Ustach; Hyeong-Reh Choi Kim
Journal:  Mol Cell Biol       Date:  2005-07       Impact factor: 4.272

5.  Proteomic identification of LASP-1 down-regulation after RNAi urokinase silencing in human hepatocellular carcinoma cells.

Authors:  Alessandro Salvi; Italia Bongarzone; Francesca Miccichè; Bruna Arici; Sergio Barlati; Giuseppina De Petro
Journal:  Neoplasia       Date:  2009-02       Impact factor: 5.715

6.  Urokinase-type plasminogen activator increases hepatocyte growth factor activity required for skeletal muscle regeneration.

Authors:  Thomas H Sisson; Mai-Huong Nguyen; Bi Yu; Margaret L Novak; Richard H Simon; Timothy J Koh
Journal:  Blood       Date:  2009-10-07       Impact factor: 22.113

Review 7.  Metastasis review: from bench to bedside.

Authors:  Ali Mohammad Alizadeh; Sadaf Shiri; Sadaf Farsinejad
Journal:  Tumour Biol       Date:  2014-08-08

8.  Activated human neutrophils rapidly release the chemotactically active D2D3 form of the urokinase-type plasminogen activator receptor (uPAR/CD87).

Authors:  Boris K Pliyev
Journal:  Mol Cell Biochem       Date:  2008-10-02       Impact factor: 3.396

9.  Extracellular alpha 6 integrin cleavage by urokinase-type plasminogen activator in human prostate cancer.

Authors:  Manolis C Demetriou; Michael E Pennington; Raymond B Nagle; Anne E Cress
Journal:  Exp Cell Res       Date:  2004-04-01       Impact factor: 3.905

Review 10.  Plasminogen Activators in Neurovascular and Neurodegenerative Disorders.

Authors:  Manuel Yepes; Yena Woo; Cynthia Martin-Jimenez
Journal:  Int J Mol Sci       Date:  2021-04-22       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.